14.89
Schlusskurs vom Vortag:
$14.68
Offen:
$14.72
24-Stunden-Volumen:
967.54K
Relative Volume:
0.17
Marktkapitalisierung:
$7.39B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$205.00M
KGV:
37.21
EPS:
0.4
Netto-Cashflow:
$372.00M
1W Leistung:
+1.80%
1M Leistung:
+10.50%
6M Leistung:
+22.92%
1J Leistung:
+16.20%
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
2500 INNOVATION WAY, GREENFIELD
Vergleichen Sie ELAN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ELAN
Elanco Animal Health Inc
|
14.88 | 7.40B | 4.45B | 205.00M | 372.00M | 0.40 |
![]()
ZTS
Zoetis Inc
|
149.47 | 69.30B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.54 | 47.50B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
HLN
Haleon Plc Adr
|
9.59 | 44.47B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.24 | 18.83B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
297.08 | 13.43B | 2.99B | 1.21B | 1.13B | 25.06 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-17 | Hochstufung | Leerink Partners | Market Perform → Outperform |
2025-06-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
2024-12-09 | Eingeleitet | UBS | Buy |
2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2024-01-05 | Hochstufung | Stifel | Hold → Buy |
2023-12-19 | Eingeleitet | Jefferies | Buy |
2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-07-21 | Herabstufung | Goldman | Buy → Sell |
2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
2021-10-28 | Herabstufung | Stifel | Buy → Hold |
2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
2021-04-15 | Eingeleitet | Stifel | Buy |
2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
2020-12-09 | Herabstufung | Argus | Buy → Hold |
2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
2020-08-04 | Fortgesetzt | Goldman | Buy |
2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2019-09-23 | Eingeleitet | Barclays | Overweight |
2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
2019-08-15 | Hochstufung | UBS | Sell → Neutral |
2019-05-23 | Eingeleitet | Guggenheim | Neutral |
2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
2019-01-23 | Eingeleitet | UBS | Sell |
2019-01-15 | Eingeleitet | Argus | Buy |
2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
What drives Elanco Animal Health Incorporated stock priceExplosive portfolio gains - jammulinksnews.com
What analysts say about Elanco Animal Health Incorporated stockMassive portfolio appreciation - jammulinksnews.com
Is Elanco Animal Health Incorporated a good long term investmentOverwhelming financial success - Autocar Professional
Veterinary Oncology Market Growth in Future Scope 2025-2032 | - openPR.com
Veterinary DermatologyCompany Evaluation Report 2025 | Zoetis, Elanco, and Boehringer Ingelheim Dominate with Global Reach, Innovative Portfolios, and Strategic Expansion - Yahoo Finance
Leerink Partnrs Has Strong Estimate for ELAN FY2027 Earnings - Defense World
Xponance Inc. Has $256,000 Stock Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco Animal Health Incorporated Stock Analysis and ForecastRecord-breaking capital gains - jammulinksnews.com
M&T Bank Corp Sells 1,445 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
FY2025 Earnings Forecast for ELAN Issued By Leerink Partnrs - Defense World
Elanco Animal Health (NYSE:ELAN) Raised to “Outperform” at Leerink Partners - Defense World
Elanco Animal Health (ELAN) Soars 1.34% on Upgrade - AInvest
Bank of New York Mellon Corp Sells 47,745 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Leerink upgrades Elanco on pet health momentum, downgrades Zoetis By Investing.com - Investing.com Canada
Elanco Animal Health Inc (ELAN) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com
This Mondelez International Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Leerink Partners upgrades Elanco Animal Health stock rating to Outperform By Investing.com - Investing.com Canada
Elanco (ELAN) Upgraded on Promising Pet Health Launches and Grow - GuruFocus
Elanco launches cattle respiratory vaccine - Beef Magazine
BiomEdit raises $18.4m Series B to expand designer probiotics platform - AgFunderNews
Are Options Traders Betting on a Big Move in ELAN Stock? - TradingView
Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement - ETX View
Elanco's dog flu vaccine gets USDA nod - MSN
Neurizon, Elanco sign deal to advance ALS therapy NUZ-001 - ALS News Today
Elanco gets US Agriculture department nod for TruCan (ELAN:NYSE) - Seeking Alpha
USDA Approves Elanco's New Vaccine for Canine Influenza - MarketScreener
Elanco receives USDA nod for Trucan Ultra Civ canine flu vaccine - MarketScreener
Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection - PR Newswire
Revolutionary Canine Flu Vaccine Shows 100% Protection: Elanco's New TruCan Ultra Gets USDA Green Light - Stock Titan
Elanco Animal Health (ELAN) Shares Soar 1.94% Amid KBC Group NV Stake Reduction - AInvest
Levi & Korsinsky Notifies Elanco Animal Health Incorporated Investors of a Class Action Lawsuit and Upcoming DeadlineELAN - ACCESS Newswire
Elanco in licensing pact with Australia’s Neurizon (ELAN:NYSE) - Seeking Alpha
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 - Nasdaq
The Analyst Verdict: Elanco Animal Health In The Eyes Of 4 Experts - Benzinga
5 Revealing Analyst Questions From Elanco’s Q1 Earnings Call - Yahoo Finance
Duff & Phelps Provided a Fairness Opinion to Elanco in Connection with its Agreement to Acquire Bayer's Animal Health Business - Kroll
Elanco Releases 2024 Impact Report and Introduces New Framework - ACCESS Newswire
Elanco Animal Health: A Catalyst-Driven Revaluation in Agri-Sciences - AInvest
Elanco Animal Health Amends Receivables Loan Agreement - TipRanks
Shareholders in Elanco Animal Health (NYSE:ELAN) have lost 37%, as stock drops 3.5% this past week - Yahoo Finance
Zoetis Stock Is Falling. Why the Animal-Health Company Was Downgraded. - Barron's
Elanco (ELAN) Gains Attention Amid Competitive Market Shifts | E - GuruFocus
United States Veterinary Pain Management Market Size, Share & - openPR.com
Harbor Capital Advisors Inc. Has $9.41 Million Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from - GuruFocus
Elanco (ELAN) Awaits European Approval for Zenrelia in Dogs - GuruFocus
Elanco gains positive EMA opinion for Zenrelia for itching in dogs - Seeking Alpha
Elanco (ELAN) Awaits EU Approval for Veterinary Drug Zenrelia | ELAN Stock News - GuruFocus
Elanco’s dog allergy treatment Zenrelia gets positive EU opinion By Investing.com - Investing.com Canada
Elanco Gets 'Positive Opinion' on Canine Itch Drug From European Medicines Agency - marketscreener.com
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) | ELAN Stock News - GuruFocus
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):